174 related articles for article (PubMed ID: 17211064)
1. Erythrocyte deformability does not seem to be altered in Behçet's disease.
Simó M; Ricart JM; Santaolaria M; Ortí G; Vayá A
Clin Hemorheol Microcirc; 2007; 36(1):83-8. PubMed ID: 17211064
[TBL] [Abstract][Full Text] [Related]
2. Do hemorheological alterations play any role in the development of thrombotic events in Behçet's disease?
Vayá A; Ricart J; Todolí J; Micó L; Contreras T; Aznar J
Clin Hemorheol Microcirc; 2004; 30(3-4):411-4. PubMed ID: 15258375
[TBL] [Abstract][Full Text] [Related]
3. Decreased erythrocyte deformability in Behçet's disease.
Usküdar O; Erdem A; Demiroğlu H; Dikmenoğlu N
Clin Hemorheol Microcirc; 2005; 33(2):89-94. PubMed ID: 16151256
[TBL] [Abstract][Full Text] [Related]
4. Erythrocyte aggregation in Behçet's disease determined with the Sefam and Myrenne aggregometer. Lack of association with thrombosis and uveitis.
Ricart JM; Vayá A; Todolí J; Santaolaria ML; Calvo J; Aznar J
Clin Hemorheol Microcirc; 2005; 33(4):389-96. PubMed ID: 16317248
[TBL] [Abstract][Full Text] [Related]
5. Platelet activation and red blood cell phosphatidylserine exposure evaluated by flow cytometry in patients with Behçet's disease: are they related to thrombotic events?
Martínez M; Ricart JM; Ruiz-Aja S; Rus A; Todolí J; Calvo J; Vayá A
Pathophysiol Haemost Thromb; 2007; 36(1):18-22. PubMed ID: 18332610
[TBL] [Abstract][Full Text] [Related]
6. Haemorheological alterations in Behçet's disease are not related to a tendency for venous thrombosis.
Ricart JM; Vaya A; Todolí J; Calvo J; Contreras MT; España F; Aznar J; Corella D
Thromb Res; 2005; 115(5):399-404. PubMed ID: 15810159
[TBL] [Abstract][Full Text] [Related]
7. Reduced erythrocyte deformability in active and untreated Behçet's disease patients.
Tatlican S; Duran FS; Eren C; Eskioglu F; Dikmenoglu N; Oktay B; Durmazlar SP; Canpolat F
Int J Dermatol; 2010 Feb; 49(2):167-71. PubMed ID: 20465640
[TBL] [Abstract][Full Text] [Related]
8. Erythrocyte deformability in anaemic patients with reticulocytosis determined by means of ektacytometry techniques.
Simó M; Santaolaria M; Murado J; Pérez ML; Corella D; Vayá A
Clin Hemorheol Microcirc; 2007; 37(3):263-7. PubMed ID: 17726256
[TBL] [Abstract][Full Text] [Related]
9. Thrombin activatable fibrinolysis inhibitor in Behçet's disease.
Donmez A; Aksu K; Celik HA; Keser G; Cagirgan S; Omay SB; Inal V; Aydin HH; Tombuloglu M; Doganavsargil E
Thromb Res; 2005; 115(4):287-92. PubMed ID: 15668188
[TBL] [Abstract][Full Text] [Related]
10. Significance of serum interleukin-8 levels in patients with Behcet's disease: high levels may indicate vascular involvement.
Durmazlar SP; Ulkar GB; Eskioglu F; Tatlican S; Mert A; Akgul A
Int J Dermatol; 2009 Mar; 48(3):259-64. PubMed ID: 19261013
[TBL] [Abstract][Full Text] [Related]
11. Erythrocyte deformability in morbid obesity before bariatric surgery. Influence of abdominal obesity.
Vayá A; Cámara R; Hernádez-Mijares A; Romagnoli M; Solá E; Corella D; Laiz B
Clin Hemorheol Microcirc; 2010; 46(4):313-20. PubMed ID: 21187580
[TBL] [Abstract][Full Text] [Related]
12. Association of the R92Q TNFRSF1A mutation and extracranial deep vein thrombosis in patients with Behçet's disease.
Amoura Z; Dodé C; Hue S; Caillat-Zucman S; Bahram S; Delpech M; Grateau G; Wechsler B; Piette JC
Arthritis Rheum; 2005 Feb; 52(2):608-11. PubMed ID: 15692984
[TBL] [Abstract][Full Text] [Related]
13. Behcet disease in adult Druzes in north Israel: the influence of ethnic origin on disease expression and severity.
Rozenbaum M; Boulman N; Slobodin G; Zisman D; Mader R; Yankevitch A; Weinberger A; Rosner I
J Clin Rheumatol; 2007 Jun; 13(3):124-7. PubMed ID: 17551376
[TBL] [Abstract][Full Text] [Related]
14. Activated protein C levels in Behçet's disease and risk of venous thrombosis.
Navarro S; Ricart JM; Medina P; Vayá A; Villa P; Todolí J; Estellés A; Micó ML; Aznar J; España F
Br J Haematol; 2004 Aug; 126(4):550-6. PubMed ID: 15287949
[TBL] [Abstract][Full Text] [Related]
15. Lack of association between hemorheological alterations and upper-extremity deep vein thrombosis.
Vaya A; Martinez Triguero M; Romagnoli M; López M; Ricart A; Corella D
Clin Hemorheol Microcirc; 2009; 41(4):279-85. PubMed ID: 19318721
[TBL] [Abstract][Full Text] [Related]
16. Influence of lipids and obesity on haemorheological parameters in patients with deep vein thrombosis.
Vayá A; Falcó C; Simó M; Ferrando F; Mira Y; Todolí J; España F; Corella D
Thromb Haemost; 2007 Sep; 98(3):621-6. PubMed ID: 17849051
[TBL] [Abstract][Full Text] [Related]
17. Erythrocyte deformability in obesity measured by ektacytometric techniques.
Solá E; Vayá A; Santaolaria ML; Hernández-Mijares A; Réganon E; Vila V; Martínez-Sales V; Corella D
Clin Hemorheol Microcirc; 2007; 37(3):219-27. PubMed ID: 17726251
[TBL] [Abstract][Full Text] [Related]
18. Circulated activated platelets and increased platelet reactivity in patients with Behçet's disease.
Akar S; Ozcan MA; Ateş H; Gürler O; Alacacioglu I; Ozsan GH; Akkoç N; Ozkan S; Demirkan F; Onen F
Clin Appl Thromb Hemost; 2006 Oct; 12(4):451-7. PubMed ID: 17000890
[TBL] [Abstract][Full Text] [Related]
19. Vascular involvement in Behçet's disease: a retrospective analysis of 2319 cases.
Sarica-Kucukoglu R; Akdag-Kose A; KayabalI M; Yazganoglu KD; Disci R; Erzengin D; Azizlerli G
Int J Dermatol; 2006 Aug; 45(8):919-21. PubMed ID: 16911374
[TBL] [Abstract][Full Text] [Related]
20. Vascular endothelial growth factor and monocyte chemoattractant protein-1 in Behçet's patients with venous thrombosis.
Bozoglu E; Dinc A; Erdem H; Pay S; Simsek I; Kocar IH
Clin Exp Rheumatol; 2005; 23(4 Suppl 38):S42-8. PubMed ID: 16273763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
